Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Clinical and Experimental Immunology
|
June 1, 1982
Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells
P C Patel, J Menezes
Annals of Allergy
|
April 1, 1992
Occupational asthma caused by exposure to cooking lobster in the work environment: a case report
P C Patel, D W Cockcroft
Applied and Environmental Microbiology
|
December 1, 1978
Isolation and identification of the cytoplasmic membrane from Saccharomyces carlsbergensis by radioactive labeling
M J Lewis, P C Patel
Clinical Chemistry
|
October 1, 1986
Use of monoclonal and polyclonal antibodies to detect prostatic acid phosphatase by immunoblotting
P C Patel, L Aubin, J Côte
Infection and Immunity
|
October 1, 1982
Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines
P C Patel, G Dorval, J Menezes
International Journal of Cancer
|
June 19, 1991
Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clones
M Khyatti, P C Patel, J Menezes
International Journal of Cancer
|
September 15, 1981
Staphylococcal protein A enhances natural killing activity against lymphoid tumor cell lines
P C Patel, I Stefanescu-Soare, J Menezes
European Journal of Immunology
|
December 1, 1990
A novel thymic epithelial adhesion molecule
C Couture, P C Patel, E F Potworowski
The American Journal of Medicine
|
July 20, 1982
Effect of 9-(2-hydroxyethoxymethyl)guanine on viral-specific polypeptide synthesis in human cytomegalovirus-infected cells
E C Mar, P C Patel, E S Huang
Journal of Virology
|
February 1, 1991
Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity
M Khyatti, P C Patel, I Stefanescu, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Clinical and Experimental Immunology
|
June 1, 1982
Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells
P C Patel, J Menezes
Annals of Allergy
|
April 1, 1992
Occupational asthma caused by exposure to cooking lobster in the work environment: a case report
P C Patel, D W Cockcroft
Applied and Environmental Microbiology
|
December 1, 1978
Isolation and identification of the cytoplasmic membrane from Saccharomyces carlsbergensis by radioactive labeling
M J Lewis, P C Patel
Clinical Chemistry
|
October 1, 1986
Use of monoclonal and polyclonal antibodies to detect prostatic acid phosphatase by immunoblotting
P C Patel, L Aubin, J Côte
Infection and Immunity
|
October 1, 1982
Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines
P C Patel, G Dorval, J Menezes
International Journal of Cancer
|
June 19, 1991
Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clones
M Khyatti, P C Patel, J Menezes
International Journal of Cancer
|
September 15, 1981
Staphylococcal protein A enhances natural killing activity against lymphoid tumor cell lines
P C Patel, I Stefanescu-Soare, J Menezes
European Journal of Immunology
|
December 1, 1990
A novel thymic epithelial adhesion molecule
C Couture, P C Patel, E F Potworowski
The American Journal of Medicine
|
July 20, 1982
Effect of 9-(2-hydroxyethoxymethyl)guanine on viral-specific polypeptide synthesis in human cytomegalovirus-infected cells
E C Mar, P C Patel, E S Huang
Journal of Virology
|
February 1, 1991
Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity
M Khyatti, P C Patel, I Stefanescu, et al.
Page
of 4